Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism
NCT ID: NCT01803594
Last Updated: 2022-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2012-08-31
2015-03-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study on the Lipid-lowering Effect of Plant Sterols and Fish Oil
NCT01313988
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
NCT00360217
The Effects of a Spread With Added Plant Sterols and Omega-3 Fatty Acids on Blood Lipids
NCT02728583
A Human In Vivo Feeding Study Of The Blood Monocyte Response To Dietary Lipid Intake
NCT02101346
Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior
NCT00663871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The dietary ingredients include:
Dairy phospholipids(PC700); krill oil (K); lutein (L); and Niacin
Eligible participants will arrive to the University of California Davis (UC Davis), Ragle Human Nutrition Center on the morning of each test day after a 10-12-hr overnight fast. Upon arrival participants will fill out a questionnaire about their dietary and medication intakes and physical activity for the past 72 hours to ensure compliance. Compliant participants' weight and blood pressure will be measured and a fasting blood draw will be taken before participants consume their test meal in the form of a milkshake (control, PC700KL, PC700KL + Niacin). On each test day, participants will be given only this meal and provided with ample supply of bottled water.
Participants will only consume this test meal and water freely for the duration of the test day. Blood will be drawn serially at 2 and 4 hours postprandially. Participants will also be asked to provide 3 urine samples throughout the study: before and 2, and 4 hours after consumption of the milkshake. Participants will be tested on two additional separate test days after the first day separated by a two-week washout. The first two test days will be randomized, however the third test day will always contain niacin in order to require participants remain at Ragle for the first two hours of the study to monitor niacin flushing reactions. Participants have the option of participating in two out of three of the test days if they wish to exclude themselves from the niacin test day.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Shake
Each shake delivers 30% of each participant's calculated energy expenditure and provides 45% energy as fat, 40% energy as carbohydrate and 15% energy as protein. The shake contains whipping cream, frozen fruit, glucose polymer, and protein powder.
Control
Control shake without dietary supplements
PC700, Krill Oil, and Lutein
Each shake delivers 30% of each participant's calculated energy expenditure and provides 45% energy as fat, 40% energy as carbohydrate and 15% energy as protein. The shake contains whipping cream, frozen fruit, glucose polymer, and protein powder. Fifty percent of the fat is made up of PC700. Additionally, 3.0g Krill oil and 40mg of lutein capsules are swallowed with water.
Neptune Krill Oil capsules (Nutrigold); Lutein capsules (Jarrow Formulas); PC700 = dairy lipids (Fonterra brand)
Krill Oil
Neptune Krill Oil Gold
Lutein
Jarrow Formulas
Dairy phospholipids
PC700 manufactured by Fonterra
PC700, Krill Oil, Lutein, and Niacin
Each shake delivers 30% of each participant's calculated energy expenditure and provides 45% energy as fat, 40% energy as carbohydrate and 15% energy as protein. The shake contains whipping cream, frozen fruit, glucose polymer, and protein powder. Fifty percent of the fat is made up of PC700. Additionally, 3.0g Krill oil and 40mg of lutein capsules are swallowed with water. Nicotinic acid was added to each shake prior to consumption at a doses 5mg/kg of body weight.
Neptune Krill Oil capsules (Nutrigold); Lutein capsules (Jarrow Formulas); PC700 (Fonterra); Nicotinic acid (Natures Way)
Krill Oil
Neptune Krill Oil Gold
Lutein
Jarrow Formulas
Nicotinic acid
Natures Way
Dairy phospholipids
PC700 manufactured by Fonterra
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Krill Oil
Neptune Krill Oil Gold
Lutein
Jarrow Formulas
Nicotinic acid
Natures Way
Dairy phospholipids
PC700 manufactured by Fonterra
Control
Control shake without dietary supplements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Plasma HDL cholesterol (Less than 50 mg/dL)
Exclusion Criteria
* History of cardiovascular events: stroke, heart attack, cardiac arrhythmia
* History of peptic ulcers, gastritis
* History of gout
* History of being under care of any psychiatric conditions (schizophrenia and depression associated with response to niacin)
* Cancer
* Type 1 or 2 diabetes
* Known presence of significant metabolic disease which could impact results of study (hepatic, renal disease)
* Low blood pressure (defined as 3 consecutive readings below 100/60 mmHg at screening)
* Self report skin sensitivities; self report to rash easily
* Self report to hot flashes currently experience due to menopause
* Hypersensitivity to niacin
* Muscle disorders such as myasthenia gravis
* Pending surgery within the next 3 months
* Known allergy to study food (shellfish, fish, nut, soy)
* Known intolerance to study food (lactose intolerance)
* More than 1 serving of fish per week
* Intake of anti-inflammatory supplemental fish, krill, borage, flax, and primrose seed oils within the last 12 weeks
* Intake of dietary supplements consisting of concentrated soy isoflavones, resveratrol, other dietary polyphenols identified as modulators of lipids within the last 12 weeks
* Intake of more than 20 mg of lutein and zeaxanthin per week
* Intake of nicotinic acid (niacin) within the last 12 weeks
* Intake of anti-coagulants, blood pressure or heart medications within the last 12 weeks
* Plan to become pregnant in next 6 months
* Recent initiation (past 4 weeks) of exercise program
* Use of tobacco products
* Excessive alcohol consumption (2 drinks/day for men and 1 drink/day for women)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unilever R&D
INDUSTRY
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer T Smilowitz, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
J. Bruce German, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UC Davis, Ragle Human Nutrition Center
Davis, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dalbeth N, Gracey E, Pool B, Callon K, McQueen FM, Cornish J, MacGibbon A, Palmano K. Identification of dairy fractions with anti-inflammatory properties in models of acute gout. Ann Rheum Dis. 2010 Apr;69(4):766-9. doi: 10.1136/ard.2009.113290. Epub 2009 Aug 26.
Snow DR, Ward RE, Olsen A, Jimenez-Flores R, Hintze KJ. Membrane-rich milk fat diet provides protection against gastrointestinal leakiness in mice treated with lipopolysaccharide. J Dairy Sci. 2011 May;94(5):2201-12. doi: 10.3168/jds.2010-3886.
Mozaffarian D, Rimm EB, Herrington DM. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr. 2004 Nov;80(5):1175-84. doi: 10.1093/ajcn/80.5.1175.
Tholstrup T, Vessby B, Sandstrom B. Difference in effect of myristic and stearic acid on plasma HDL cholesterol within 24 h in young men. Eur J Clin Nutr. 2003 Jun;57(6):735-42. doi: 10.1038/sj.ejcn.1601605.
Bunea R, El Farrah K, Deutsch L. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev. 2004 Dec;9(4):420-8.
Ribaya-Mercado JD, Blumberg JB. Lutein and zeaxanthin and their potential roles in disease prevention. J Am Coll Nutr. 2004 Dec;23(6 Suppl):567S-587S. doi: 10.1080/07315724.2004.10719427.
Kiokias S, Gordon MH. Dietary supplementation with a natural carotenoid mixture decreases oxidative stress. Eur J Clin Nutr. 2003 Sep;57(9):1135-40. doi: 10.1038/sj.ejcn.1601655.
Related Links
Access external resources that provide additional context or updates about the study.
More information about the research is available on the UC Davis Foods for Health Institute's website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
264254
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.